HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content
0 Members and 0 Guests are viewing this board.
A

(Abst.) Projected study investigating relationship between fingolimod and skin cancer risk

Started by agate
0Replies
306Views
A
agate
A

Rebound syndrome in MS patients after stopping Gilenya

Started by agate
4Replies
10936Views
A
agate
A

Randomized clinical trial: 2 fingolimod doses vs. Copaxone for patients with RRMS

Started by agate
0Replies
455Views
A
agate
A

FDA approves first generics of Gilenya

Started by agate
0Replies
315Views
A
agate
A

Fingolimod and liver injury research information (PubMed)

Started by agate
0Replies
358Views
A
agate
A

(Abst.) Gilenya vs. Tecfidera in MS...

Started by agate
0Replies
516Views
A
agate
A

(Abst.) PML after fingolimod treatment

Started by agate
1Replies
706Views
A
agate
A

Gilenya shows promise in pediatric MS

Started by agate
1Replies
773Views
A
agate
A

(Abst.) Switching from Tysabri to Gilenya within 6 weeks cuts recurrence of MS disease activity

Started by agate
0Replies
604Views
A
agate
A

(AAN abst.) Alternate dosing of fingolimod for MS

Started by agate
0Replies
743Views
A
agate
A

(Abst.) Extensive white matter lesions after 2 yrs. of fingolimod: PML or MS relapse?

Started by agate
0Replies
499Views
A
agate
A

New EMA advice for PML prevention with fingolimod in MS

Started by agate
0Replies
422Views
A
agate
A

3rd PML case with Gilenya in MS

Started by agate
0Replies
437Views
A
agate
A

Gilenya label to include PML warning according to FDA

Started by agate
1Replies
478Views
A
agate
A

(Abst.) Lymphomatoid papulosis in patient on Gilenya for MS

Started by agate
0Replies
440Views
A
agate
A

Fingolimod in MS: Indication of added benefit in certain patients

Started by agate
0Replies
406Views
A
agate
A

PML case in MS patient taking Gilenya

Started by agate
0Replies
492Views
A
agate
A

Increased risk of zoster infections with Gilenya

Started by agate
1Replies
620Views
A
agate